Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05315791

Clinical Application Strategies of Maxillary Sinus Buccal Bony Window

Clinical Application Strategies of Maxillary Sinus Buccal Bony Window With Different Residual Bone Heights in Lateral Maxillary Sinus Floor Elevation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
The Dental Hospital of Zhejiang University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Through randomized controlled trials, investigators will recruit participants who need maxillary sinus floor elevation with different residual bone height, and utilize the maxillary sinus buccal bony window during the surgery. Then investigators will gather the related information of participants, collect and analyze their CBCT data, in order to help surgeons select the best operating method for different patients.

Detailed description

Through randomized controlled trials, investigators will recruit 60 participants who need maxillary sinus floor elevation with different residual bone height (0\~3mm; 3\~5mm), and utilize the maxillary sinus buccal bony window during the surgery (A: ground into pieces; B: replace the bone; C: turn inward to hold up the membrane). Then investigators will gather the related information of participants, collect and analyze their CBCT data, in order to help surgeons select the best operating method for different patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREdifferent methods for maxillary sinus floor elevationa: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Timeline

Start date
2022-03-10
Primary completion
2023-03-02
Completion
2032-12-31
First posted
2022-04-07
Last updated
2022-04-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05315791. Inclusion in this directory is not an endorsement.